BioRestorative Therapies (BRTX): Fair Value Consensus

BioRestorative Therapies (BRTX) relies on outsourcing clinical trials to external laboratories while maintaining control over cultivation methods. This price chart allows for tracking of this sector, where the current indicator is 20.05. BioRestorative Therapies (BRTX) develops drugs to treat back pain utilizing ThermoStem patent protection, while simultaneously competing against implant manufacturers and new non-invasive therapy methods.

BRTX - BioRestorative Consensus Target over the range 07/04/2022 - 11/11/2026

BioRestorative Therapies (BRTX) - metric breakdowns and financial figures

- current price and projected stock value:

Price Chart biorestorative.com|BRTX - Price Target Chart

- stock exchange capitalization data:

Market Value BioRestorative|BRTX - Real Price to Acquire Entire Company

- book capitalization indicators:

Book Price of a Share BioRestorative Therapies|BRTX - Company Net Assets|Capitalization to Book Value Ratio biorestorative.com|BRTX - Aggregate Company Assets

- business debt structure and liquidity details:

Total Debt to Capital Coefficient BioRestorative Therapies|BRTX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio biorestorative.com|BRTX - Company Aggregate Debts|Debts to Book Value BioRestorative|BRTX - Company Long-Term Debt|Company Current Liabilities BioRestorative Therapies|Quick Liquidity Indicator biorestorative.com

- earnings and market ratios statistics:

BRTX - Net Profit|Expected Net Profit BioRestorative Therapies|BRTX - Price to Earnings Ratio|Future Price to Earnings biorestorative.com|BRTX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioRestorative|BRTX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters BioRestorative Therapies|BRTX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months biorestorative.com|BRTX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year BioRestorative Therapies

General company analysis:BRTX - BioRestorative Therapies Inc

BioRestorative Therapies (BRTX) is developing innovative treatments for spinal pain through partnerships with medical centers testing cell therapies. An analysis of the median analyst target price allows for an objective valuation of the asset by aggregating investment house forecasts to eliminate market noise and emotional volatility. The dynamics of this indicator serve as a fundamental benchmark for the business's fair value, helping investors assess the company's growth potential while excluding speculative risks.

Competitors of BioRestorative Therapies